6
MNiSW
58.21
ICV
REVIEW PAPER
 
CC BY-NC-ND 3.0
 
 

State of knowledge concerrning congenital cmv infection among pregnant women and those who plan pregnancy

 
1
Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny
MONZ 2017;23(3):179–184
KEYWORDS:
TOPICS:
ABSTRACT:
Introduction:
Cytomegalovirus (CMV) is the most common cause of congenital infections worldwide. Congenital CMV infection concerns an average of 0.64% live births worldwide, the value varies depending on the tested population from 0.3% – 2.3%. Every day in the world 2500 children infected with CMV are born, and 1/5 of them die or develop permanent disability.

Objective:
Review of literature concerning the current state of knowledge about congenital CMV infection, its consequences and possibilities of prevention among pregnant women and planning to become pregnant.

Brief description of the state of knowledge:
Surveys carried out in various countries revealed that most of the pregnant women or planning to become pregnant are not aware of what consequences for the fetus may have CMV infection. A high percentage of women did not know, never heard and never did not read anything about CMV infection in pregnancy. Most of the respondents could not give specific symptoms associated with congenital CMV infection, risk factors, routes of transmission and ways to prevent infection. Mental retardation and hearing loss were the most frequently indicated consequence of this infection. Among the hygienic behavior, which can prevent infection with CMV women exchanged primarily hand washing, avoiding contact with urine and children kissing on the lips.

Summary:
The measures taken to prevent congenital CMV infection are still inadequate and disproportionate to the consequences posed by this infection for pregnant women and their children. Therefore, it is important to raise awareness of congenital CMV infection and its consequences, and possibilities available to prevent him not only among women planning to become pregnant or pregnant women, but the general public.

CORRESPONDING AUTHOR:
Agnieszka Trzcińska   
Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny, Chocimska 24, 00-791 Warszawa, Polska
 
REFERENCES:
1. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus sero¬prevalence and demographic characteristics associated with infection. Rev MedVirol. 2010; 20(4): 202–213.
2. Mocarski ES, Shenk T, Pass RF. Cytomegalovirus. W: Knipe DM, Howley PM (red.). Fields Virology (Vol. 5). USA: Lippincott Williams and Wilkins; 2007. p. 2701–2772.
3. Lazzarotto T, Lanari M. Why is cytomegalovirus the most frequent cause of congenital infection? Expert Rev. Anti Infect Ther. 2011; 9(10): 841–843.
4. Griffiths PD. Cytomegalovirus. W: Zuckerman AJ, Banatvala JE, Patti¬son JR, Griffiths PD (red.). Principles and practice of clinical virology. 5th ed. London: John Wiley & Sons Ltd; 2004. p. 85–122.
5. Doerr HW. Fighting cytomegalovirus caused diseases: the immunologic approach. Med Microbiol Immunol. 2016; 205(6): 511–512.
6. Sissons JGP, Wills MR. How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future. Med. Microbiol Immunol. 2015; 204(3): 307–316.
7. Alex MR. Congenital cytomegalovirus: implications for maternal-child nursing. MCN Am J Matern Child Nurs. 2014; 39(2): 122–129.
8. Basha J, Iwasenko JM, Robertson P, Craig ME, Rawlinson WD. Conge¬nital cytomegalovirus infection is associated with high maternal socio¬-economic status and corresponding low maternal cytomegalovirus seropositivity. J Pediatr Child Health. 2015; 50(5): 368–372.
9. Demmler-Harrison GJ. Congenital cytomegalovirus infection the ele¬phant in our living room. JAMA Pediatr. 2016; 170(12): 1142–1144.
10. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemio¬logy of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007; 17(4): 253–276.
11. Marin LJ, Santos de Carvalho Cardoso E, Bispo Sousa SM, Debortoli de Carvalho L, Marques Filho MF, Raiol MR i wsp. Prevalence and clinical aspects of CMV congenital infection in a low-income population. Virol J. 2016; 13: 148 doi: 10.1186/s12985–016–0604–5.
12. Lombardi G, Garofoli F, Stronati M. Congenital cytomegalovirus infec¬tion: treatment, sequelae and follow-up. J Matern Fetal Neonatal Med. 2010; 23(Suppl 3): 45–48.
13. Cannon MJ, Davis KF. Washing our hands of the congenital cyto¬megalovirus disease epidemic. BMC Public Health. 2005; 5: 70. doi: 10.1186/1471-2458-5-70.
14. Ross DS, Dollard SC, Victor M, Sumartojo E, Cannon MJ. The epide¬miology and prevention of congenital cytomegalovirus infection and disease: activities of the Centers for Disease Control and Prevention Workgroup. J Womens Health. 2006; 15(3): 224–229.
15. Walter E, Brennig C, Schöllbauer V. How to save money: congenital CMV infection and the economy. W: Halwachs-Baumann G (red.). Congenital Cytomegalovirus Infection. Epidemiology, Diagnosis, The¬rapy. Wien: Springer-Verlag; 2011. p. 121–144.
16. Adler SP. Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers. Pediatr Infect Dis J. 1991; 10(8): 584–590.
17. Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011; 21(4): 240–255.
18. Adler SP. Screening for cytomegalovirus during pregnancy. Infect Dis Obstet Gynecol. 2011; 2011: 1–9. doi: 10.1155/2011/942937.
19. Grosse S, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008; 41(2): 57–62.
20. Nyholm JL, Schleiss MR. Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health. 2010; 2: 23–35.
21. Plachter B. Prospects of a vaccine for the prevention of congenital cyto¬megalovirus disease. Med Microbiol Immunol. 2016; 205(6): 537–547.
22. Britt W. Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy. Med Microbiol Immunol. 2015; 204(3): 263–271.
23. Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus nonprimary maternal infection. Clin Infect Dis. 2011; 52(2): 11–13.
24. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr. 2000; 137(1): 90–95.
25. Siennicka J, Dunal-Szczepaniak M, Trzcińska A, Godzik P, Rosińska M. High Seroprevalence of CMV Among Women of Childbearing Age Implicates High Burden of Congenital Cytomegalovirus Infection in Poland. Pol J Microbiol. 2016; 65(4): 425–432.
26. Wang C, Dollard SC, Amin MM, Bialek SR. Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States. PLoS ONE. 2016; 11:e0151996. doi:10.1371/journal.pone.0151996.
27. Schleiss MR. Role of breast milk in acquisition of cytomegalovirus infection: recent advances. Curr Opin Pediatr. 2006; 18(1): 48–52.
28. Bodeus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol. 1999; 93(5): 658–660.
29. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992; 326(10): 663–667.
30. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985; 313(20): 1270–1274.
31. Dunal M, Trzcińska A, Siennicka J. Wirus cytomegalii – problem zakażeń wrodzonych. Post. Mikrobiol. 2013; 52(1): 17–28.
32. Swanson EC, Schleiss MR. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am. 2013; 60(2): 335–349.
33. Naing ZW, Scott GM, Shand A, Hamilton ST, van Zuylen WJ, Basha J i wsp. Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention. Aust N Z J Obstet Gynaecol. 2016; 56(1): 9–18.
34. Shet A. Congenital and Perinatal Infections: Throwing New Light with an Old TORCH. Indian J Pediatr. 2011; 78(1): 88–95.
35. Fowler KB, Boppana SB. Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006; 35(2): 226–231.
36. Dahle AJ, Fowler KB, Wright JD, Boppana SB, Britt WJ, Pass RF. Lon¬gitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000; 11(5): 283–290.
37. Schleiss MR. Cytomegalovirus vaccines under clinical development. J Virus Erad. 2016; 2(4): 198–207.
38. van Zuylen WJ, Hamilton ST, Naing Z, Hall B, Shand A, Rawlinson WD. Congenital cytomegalovirus infection: Clinical presentation, epi-demiology, diagnosis and prevention. Obstet Med. 2014; 7(4): 140–146.
39. Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Châtelet I, Senat MV, Frydman R i wsp. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol. 2009; 46(Suppl. 4): 49–53.
40. Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child¬-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr. 2004; 145(4): 485–491.
41. Morioka I, Sonoyama A, Tairaku S, Ebina Y, Nagamata S, Morizane M, i wsp. Awareness of and knowledge about mother-to-child infections in Japanese pregnant women. Congenit Anom (Kyoto). 2014; 54(1): 35–40.
42. Cordier AG, Guitton S, Vauloup-Fellous C, Grangeot-Keros L, Ayoubi JM, Benachi A, i wsp. Awareness of congenital cytomegalovirus infection among pregnant women in France. J Clin Virol. 2012; 53(4): 332–337.
43. Wizman S, Lamarre V, Coic L, Kakkar F, Le Meur JB, Rousseau C, i wsp. Awareness of cytomegalovirus and risk factors for susceptibility among pregnant women in Montreal, Canada. BMC Pregnancy Childbirth. 2016; 16:54. doi: 10.1186/s12884–016–0844–9.
44. Pereboom MTR, Manniën J, Spelten ER, Schellevis FG, Hutton EK. Observational study to assess pregnant women›s knowledge and beha-viour to prevent toxoplasmosis, listeriosis and cytomegalovirus. BMC Pregnancy Childbirth. 2013; 13: 98. doi: 10.1186/1471–2393–13–98.
45. Lim SL, Tan WC, Tan LK. Awareness of and attitudes toward congenital cytomegalovirus infection among pregnant women in Singapore. Int J Gynaecol Obstet. 2012; 117(3): 268–272.
46. Willame A, Blanchard-Rohner G, Combescure C, Irion O, Posfay-Barbe K, Martinez de Tejada B. Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study. Int J Environ Res Public Health. 2015; 12(12): 15285–15297.
47. Thackeray R, Magnusson BM. Women’s attitudes toward practicing cytomegalovirus prevention behaviors. Prev Med Rep. 2016; 4: 517–524. doi: 10.1016/j.pmedr.2016.09.008.
48. Price SM, Bonilla E, Zador P, Levis DM, Kilgo CL, Cannon MJ. Edu¬cating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Women›s Health. 2014; 14: 144. doi: 10.1186/s12905–014–0144–3.
49. Cannon MJ, Westbrook K, Levis D, Schleiss MR, Thackeray R, Pass RF. Awareness of and behaviors related to child-to-mother transmission of cytomegalovirus. Prev Med. 2012; 54(5): 351–357.
50. Harvey J, Dennis CL. Hygiene interventions for prevention of cyto¬megalovirus infection among childbearing women: systematic review. J Adv Nurs. 2008; 63(5): 440–450.
eISSN:2084-4905
ISSN:2083-4543